{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:02:33Z","timestamp":1789570953346,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09975-y","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:05:47Z","timestamp":1789567547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond antibiotic duration in acute cholangitis: system-level determinants after biliary drainage"],"prefix":"10.1186","volume":"27","author":[{"given":"Linda","family":"Pasta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Bronte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Aragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"9975_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-026-09524-7","volume":"27","author":"AG Overdevest","year":"2026","unstructured":"Overdevest AG, Sieswerda E, Haal S, et al. Antibiotic treatment for 1 day versus 4\u20137 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial. Trials. 2026;27:222.","journal-title":"Trials"},{"key":"9975_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061. https:\/\/doi.org\/10.1136\/bmj.n2061.","journal-title":"BMJ"},{"key":"9975_CR3","unstructured":"Aragona E, Affronti A, Bronte F, et al. Impact of a structured work-support system on surveillance and prevention of healthcare-associated infections: a 24-month real-world study in a Gastroenterology ward and its relationship with ward microbial pressure. Journal of Infection Prevention. Accepted for publication 1 August 2026. Manuscript ID JIP-OA-26\u20130076.R1."},{"key":"9975_CR4","volume-title":"Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva: World Health Organization; 2016."},{"issue":"5","key":"9975_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/cid\/civ495","volume":"61","author":"SR Evans","year":"2015","unstructured":"Evans SR, Rubin D, Follmann D, et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis. 2015;61(5):800\u20136. https:\/\/doi.org\/10.1093\/cid\/civ495.","journal-title":"Clin Infect Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09975-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09975-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09975-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:05:51Z","timestamp":1789567551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09975-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9975"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09975-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Linda Pasta holds a medical advisory role at PRISMED - B. Corporation, the company that developed the work-support system discussed in the manuscript, and receives no remuneration for this role. Fabrizio Bronte and Emma Aragone declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"575"}}